{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:38:04Z","timestamp":1794101884850,"version":"4.8.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/sla.0b013e3182a6183e","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T03:35:29Z","timestamp":1379388929000},"page":"731-742","source":"Crossref","is-referenced-by-count":171,"title":["Liver Resection for Colorectal Metastases after Chemotherapy"],"prefix":"10.1097","volume":"258","author":[{"given":"Luca","family":"Vigan\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Capussotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassila Oulhaci","family":"De Saussure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Mentha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rubbia-Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.","volume":"27","author":"Kopetz","year":"2009","journal-title":"J Clin Oncol"},{"key":"R2-10-20210203","first-page":"1829","article-title":"Patients with initially unresectable colorectal liver metastases: is there a possibility of cure J Clin Oncol.","volume":"27","author":"Adam","year":"2009","journal-title":""},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1634\/theoncologist.2012-0121","article-title":"The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.","volume":"17","author":"Adam","year":"2012","journal-title":"Oncologist"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1245\/s10434-010-1385-5","article-title":"Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases.","volume":"18","author":"Wicherts","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","article-title":"Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.","volume":"18","author":"Rubbia-Brandt","year":"2007","journal-title":"Ann Oncol"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"R10-10-20210203","first-page":"308","article-title":"Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.","volume":"5","author":"Wakai","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/cncr.10422","article-title":"Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases.","volume":"94","author":"Yokoyama","year":"2002","journal-title":"Cancer"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1245\/s10434-008-0023-y","article-title":"Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis.","volume":"15","author":"Wakai","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1245\/s10434-012-2628-4","article-title":"Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.","volume":"20","author":"Vigano","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bjs.5346","article-title":"Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.","volume":"93","author":"Mentha","year":"2006","journal-title":"Br J Surg"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-007-9607-1","article-title":"Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score.","volume":"15","author":"Andres","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1245\/s10434-011-2186-1","article-title":"Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades.","volume":"19","author":"Vigano","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R23-10-20210203","first-page":"183","article-title":"Hepatic resection for colorectal metastases: value for risk scoring systems Ann Surg.","volume":"246","author":"Zakaria","year":"2007","journal-title":""},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ejso.2010.03.009","article-title":"Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy.","volume":"36","author":"Gregoire","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1245\/s10434-012-2382-7","article-title":"Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases.","volume":"19","author":"Vigano","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1245\/s10434-012-2335-1","article-title":"Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.","volume":"19","author":"Poultsides","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1245\/s10434-010-0972-9","article-title":"Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOXFOLFOX.","volume":"17","author":"Klinger","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/annonc\/mdi154","article-title":"Oxaliplatin combined with irinotecan and 5-fluorouracilleucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.","volume":"16","author":"Seium","year":"2005","journal-title":"Ann Oncol"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3816\/CCC.2008.n.002","article-title":"Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer.","volume":"7","author":"Masi","year":"2008","journal-title":"Clin Colorectal Cancer"},{"key":"R30-10-20210203","first-page":"1635","article-title":"Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality J Clin Oncol.","volume":"26","author":"Adam","year":"2008","journal-title":""},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2559.2012.04208.x","article-title":"Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.","volume":"61","author":"Vreuls","year":"2012","journal-title":"Histopathology"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans.","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejso.2009.09.004","article-title":"Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.","volume":"36","author":"Pathak","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection.","volume":"7","author":"Kooby","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/hpb.12007","article-title":"The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy published online ahead of print December 27, 2012.","volume":"15","author":"Parkin","year":"2013","journal-title":"HPB (Oxford)"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ejca.2011.06.038","article-title":"Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.","volume":"47","author":"Simkens","year":"2011","journal-title":"Eur J Cancer"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11605-010-1163-5","article-title":"Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy.","volume":"14","author":"Mathur","year":"2010","journal-title":"J Gastrointest Surg"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0b013e3182a6183e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:15:57Z","timestamp":1620962157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000658-201311000-00010"}},"subtitle":["Impact of Chemotherapy-Related Liver Injuries, Pathological Tumor Response, and Micrometastases on Long-term Survival"],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e3182a6183e","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}